In this episode, Marie-Josee Toutounji, Medical affairs professional with over 20 years of experience in the pharmaceutical industry, discusses the pressing issue of unapproved content in the medical and regulatory field. The episode covers the potential risks of using unapproved content and tools in healthcare. Marie-Josee explores the challenges of implementing a continuous learning culture in the industry, with a focus on stakeholder engagement, compliance, and documentation to develop a rigorous system for training and development. The podcast provides valuable insights and tips on developing an effective learning and development system, including coaching field teams and collaboration among different teams in the industry.
former Medical Head, General Medicines Canada, Sanofi
About Marie-Josee Toutounji:
Marie-Josee brings a wealth of experience and expertise to this topic. She is a Medical Affairs professional with over 20 years of experience in the pharmaceutical industry. She is a trained and licenced pharmacist who, after working in a pharmacy, moved her career into pharmaceutics as a pharmacovigilance specialist. She held the position of Medical Head of General Medicines Canada at Sanofi until they recently relocated to Ontario– As medical head, she drove development for Canadian Medical Strategy at Sanofi.
What you will learn:
How coaching field teams is one potential solution to the use of unapproved content in the field.
How continuous learning is essential to eliminate the use of unapproved content in the pharmaceutical industry.
How effective communication and collaboration are critical to the success of field teams and how it can be implemented with the right technology tools.
Don't miss out on the valuable insights shared by our panel of experts! Click here to read the executive summary or watch the webinar recording now.
Guest LinkedIn: Marie-Josee Toutounji
Industry Insights: Bending the Spoon Blog
Keep up to date on Social Media: Twitter & LinkedIn
Have a learning journey that you want to hear more about? Email us at [email protected] or find me on LinkedIn